Re: CoQ10 conference


Sharon Hope wrote:
> "Sbharris[atsign]ix.netcom.com" <sbharris@xxxxxxxxxxxxx> wrote in message
> news:1126219469.956938.136410@xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
> >
> > Sharon Hope wrote:
> >> "Robert" <Robertitsme@xxxxxxxxxxx> wrote in message
> >> news:vI2dnWlBcuvpH4PeRVn-uQ@xxxxxxxxxx
> >> >
> >> > "Sharon Hope" <shope@xxxxxxxx> wrote in message
> >> > news:5JSdnZ8mHewt6YPeRVn-gQ@xxxxxxxxxxxxxx
> >> >> LOL.
> >> >>
> >> >> Lipitor does ~ $10 BILLION per year.
> >> >>
> >> >> You think that the non-patentable supplement CoQ10 in the food
> >> >> category,
> >> >> which MIGHT hit $200 Million per year in 2006 is in the running? You
> >> >> see
> >> >> this as an industry throwing its weight around?
> >> >
> >> > It sponsors research on it's behalf.
> >> >
> >> >>
> >> >> Remind me not to take any tips on the stock market from you.
> >> >>
> >> >> ROFL!!!
> >> >
> >> > It wasn't for the financial advantage but for the financial disclosure
> >> > of
> >> > studies you refer here to.
> >> >
> >> >>
> >> >> BTW, they haven't been able to identify a single adverse effect from
> >> > CoQ10.
> >> >> But they have seen it do incredible good in cases of Cerebellar Ataxia
> >> >> and
> >> >> Parkinson's Disease.
> >> >
> >> > Studies paid by who? That's the whole point.
> >> > They call it incredible while others call it "negative or neutral".
> >> > You want to have them do research for you?
> >> >
> >>
> >> You have yet to list a single link to a study paid for by a producer of
> >> CoQ10.
> >>
> >> Where is the evidence?
> >
> >
> > You want me to post links to CoQ10 papers in the literature paid for by
> > producers of CoQ10 products?
>
> Yes, back your claim. Your claim is counter to what was said by the
> presenters at the conference.
>
> Citations please, it is only what you would require of me.
>
> >It will be a little harder to post links
> > for abstracts at some conference you attended, because they aren't
> > published yet.
> >
> > SBH


COMMENT:

Robert has adequately answered you on the matter of the conference. As
for papers in the literature, you merely have to use pubmed and look at
CoQ10 studies in humans.

For example:

Int J Vitam Nutr Res. 1998;68(2):109-13.

Relative bioavailability of coenzyme Q10 formulations in human
subjects.
Chopra RK, Goldman R, Sinatra ST, Bhagavan HN.

Tishcon Corp., Westbury, NY 11590, USA.

The relative bioavailability of typical commercially available forms of
coenzyme Q10 (CoQ10) was compared with that of Q-Gel, a new solubilized
form of CoQ10, in human subjects in two separate trials. In the first,
standard softgel capsules containing CoQ10 suspension in oil,
powder-filled hardshell capsules and powder-based tablets were tested
along with Q-Gel using a daily dosage of 120 mg for three weeks. The
baseline plasma CoQ10 values were all very tight (0.50-0.52
microgram/mL) and after three weeks the values were 1.37, 1.63 and 1.60
micrograms/mL for the first three products and 3.31 micrograms/mL for
Q-Gel. The relative bioavailability calculated using the areas under
the plasma CoQ10 curve (AUC) were (micrograms/mL x time in days) 7.16
(100%), 8.97 (125%), 9.19 (128%) and for Q-Gel 22.86 (319%). The second
trial, carried out to replicate the findings in the first, employed
only two groups, namely the standard softgel capsules containing the
suspension and Q-Gel, and the duration was extended to four weeks.
Plasma CoQ10 values were: baseline 0.40 and 0.38 and after four weeks
1.26 and 2.80; the corresponding AUCs were: 8.33 (100%) and 22.75
(273%). Thus, the data from both the trials show that Q-Gel, the new
solubilized form of CoQ10, is vastly superior to typical commercially
available preparations of CoQ10. This means much lower doses of Q-Gel
will be required to rapidly reach and maintain adequate blood CoQ10
values than with any of the other currently available products.

PMID: 9565826 [PubMed - indexed for MEDLINE]

============================


COMMENT:

Please note that this study is FROM Tishcon corporation. Google
Tishcon. Tishcon is the owner of the basic Goldman emulsion patent for
the CoQ10 "BioSolve" system used in "Q-Gel" products, as mentioned in
the study above. They license this technology to products like
Solanova's "Q-gel" line. But you have to be a real connoiseur of the
industry to know they also licence it to Twinlab for Twinlab's
"TWINSORB" CoQ10 line. Twinlab doesn't want you to see from their
bottle that the technology isn't theirs.

Note this drug study was done in India. It's cheap to do human trials
in India, and you can get any results you like. Just ask <g>.

Is that enough inside info for one day? Do you need to sleep with mommy
tonight?

SBH

.